A recent report by Robert Neil in the publication Medtech Insight focuses on the race among medical device and pharmaceutical companies to develop closed loop artificial pancreas (AP) systems. The comprehensive report, titled “The Artificial Pancreas: A Race to the Finish,” provides a detailed overview of the ongoing efforts to develop AP systems, with updates and analysis on the projects and products under development by all of the major players in the field.
The article quotes JDRF’s vice president of treatment therapies, Aaron Kowalski, Ph.D., who discusses JDRF’s focus on achieving the best outcomes for patients with type 1 diabetes (T1D). It also includes a listing of ongoing clinical trials, many of which have been funded by the JDRF Artificial Pancreas Consortium.
Please click here to access a PDF of the article.